Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.

Sign up for a 7-day FREE trial today!

Latest News in Intellectual Property

• February 09, 2026

  High Court Asked To Take Up Malpractice Case Against Akin

  A former Cornell University graduate student wants the U.S. Supreme Court to review the dismissal of his suit accusing Akin Gump Strauss Hauer & Feld LLP attorneys of manipulating patent litigation to steal his DNA sequencing intellectual property.

• February 09, 2026

  Production Co. Fights To Keep Film Credits Suit In Chancery

  A Delaware Chancery Court judge on Monday pondered whether she still has authority to hear a dispute over a 2024 Maltese-shot war action film, after both sides agreed that the case's remaining claims now center solely on money damages rather than equitable relief.

• February 06, 2026

  Takeda Can't Ax Most Of Heartburn Drug Pay-For-Delay Suit

  Takeda Pharmaceutical Co. and TWi Pharmaceuticals must face most of a proposed antitrust class action accusing them of delaying the release of the generic version of Takeda's heartburn medication Dexilant, causing Walgreens, Kroger and other retailers to pay more for the brand-name drug, a California federal judge ruled Friday.

• February 06, 2026

  OpenAI Can Keep Atty Comms Secret After All, Judge Says

  A New York federal judge Friday set aside a magistrate judge's order requiring OpenAI's in-house attorneys to share their internal communications regarding deleted training datasets with authors suing over alleged copyright infringement, holding that the conclusions underlying that decision were "clearly erroneous or contrary to law."

• February 06, 2026

  HHS Refers Hims & Hers To DOJ Amid Compound Drug Fight

  U.S. Department of Health and Human Services general counsel Mike Stuart announced Friday that his office referred Hims & Hers Health Inc. to the U.S. Department of Justice for investigation, a day after Novo Nordisk A/S threatened litigation over what it called the telehealth company's "knockoff" version of its popular weight loss drug Wegovy.

See more Intellectual Property news